Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
597.15
-1.87 (-0.31%)
At close: May 16, 2024, 4:00 PM
560.00
-37.15 (-6.22%)
After-hours: May 16, 2024, 7:33 PM EDT
Thermo Fisher Market Cap
Thermo Fisher has a market cap or net worth of $228.35 billion as of May 16, 2024. Its market cap has increased by 10.72% in one year.
Market Cap
228.35B
Enterprise Value
256.70B
1-Year Change
10.72%
Ranking
Category
Stock Price
$597.15
Market Cap Chart
Since December 1, 1998, Thermo Fisher's market cap has increased from $2.71B to $228.35B, an increase of 8,327.00%. That is a compound annual growth rate of 19.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 15, 2024 | 228.66B | 0.71% |
May 14, 2024 | 227.04B | 0.69% |
May 13, 2024 | 225.48B | -0.39% |
May 10, 2024 | 226.37B | 2.61% |
May 9, 2024 | 220.61B | 0.75% |
May 8, 2024 | 218.97B | 0.13% |
May 7, 2024 | 218.67B | -0.12% |
May 6, 2024 | 218.93B | 0.20% |
May 3, 2024 | 218.49B | 0.30% |
May 2, 2024 | 217.82B | -0.65% |
May 1, 2024 | 219.25B | 1.10% |
Apr 30, 2024 | 216.86B | -1.42% |
Apr 29, 2024 | 219.98B | 0.57% |
Apr 26, 2024 | 218.72B | 0.33% |
Apr 25, 2024 | 218.01B | -0.98% |
Apr 24, 2024 | 220.17B | 0.49% |
Apr 23, 2024 | 219.10B | 4.78% |
Apr 22, 2024 | 209.10B | 0.66% |
Apr 19, 2024 | 207.73B | 0.60% |
Apr 18, 2024 | 206.49B | -1.05% |
Apr 17, 2024 | 208.67B | -1.32% |
Apr 16, 2024 | 211.46B | -0.60% |
Apr 15, 2024 | 212.72B | -1.30% |
Apr 12, 2024 | 215.53B | -1.63% |
Apr 11, 2024 | 219.09B | 0.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UnitedHealth Group | 472.81B |
Johnson & Johnson | 364.32B |
Merck & Co. | 325.87B |
AbbVie | 285.35B |
AstraZeneca | 238.86B |
Novartis AG | 202.12B |
Danaher | 192.03B |
Abbott Laboratories | 180.94B |